| Propensity score weighting | |||||
---|---|---|---|---|---|---|
With CKD | Without CKD | |||||
ACEi (n = 932) | ARB (n = 2135) | Standardized mean difference | ACEi (n = 5966) | ARB (n = 10,623) | Standardized mean difference | |
Duration from DM to index date (years) | 3.50 ± 3.33 | 3.52 ± 2.09 | −0.0049 | 3.00 ± 3.11 | 3.01 ± 2.29 | −0.0035 |
Age (years) (mean ± SD) | 65.5 ± 13.3 | 65.2 ± 8.8 | 0.0276 | 60.8 ± 12.9 | 60.6 ± 9.8 | 0.0175 |
Age group (years) | Â | Â | 0.0123 | Â | Â | 0.0049 |
 20–49 (%) | 14.70 | 15.06 |  | 21.81 | 21.92 |  |
 50–64 (%) | 32.08 | 32.25 |  | 40.56 | 40.69 |  |
 65+ (%) | 53.22 | 52.69 |  | 37.63 | 37.39 |  |
Male sex | 59.12 % | 59.21 % | −0.0019 | 59.52 % | 59.62 % | −0.0019 |
Congestive heart failure | 8.05 % | 8.15 % | −0.0039 | 3.96 % | 3.94 % | 0.0006 |
Stroke | 16.20Â % | 16.15Â % | 0.0014 | 12.19Â % | 12.16Â % | 0.0007 |
Malignant dysrhythmia | 0.21Â % | 0.21Â % | 0.0014 | 0.49Â % | 0.48Â % | 0.0011 |
Cardiogenic shock | 0.64 % | 0.73 % | −0.0102 | 0.27 % | 0.27 % | −0.0011 |
MI/PCI | 5.15Â % | 5.08Â % | 0.0030 | 4.98Â % | 4.96Â % | 0.0008 |
CABG | 0.11 % | 0.11 % | −0.0010 | 0.52 % | 0.51 % | 0.0008 |
Thrombolysis therapy | 0.00 % | 0.00 % | −0.0002 | 0.28 % | 0.28 % | 0.0012 |
Hyperlipidemia | 59.44 % | 59.86 % | −0.0085 | 53.77 % | 53.77 % | −0.0017 |
Incidence of ESRDa | 1.39 | 2.34 | Â | 0.30 | 0.37 | Â |
(95 % CI) | (1.00−1.78) | (1.80−2.89) |  | (0.23−0.37) | (0.29−0.46) |  |